UBS Group Lowers Clorox (NYSE:CLX) Price Target to $154.00

Clorox (NYSE:CLX) had its price objective lowered by analysts at UBS Group from $176.00 to $154.00 in a research note issued on Thursday,Benzinga reports. The firm presently has a “neutral” rating on the stock. UBS Group’s price target indicates a potential upside of 10.32% from the stock’s current price.

A number of other analysts have also weighed in on the stock. StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Royal Bank of Canada reiterated a “sector perform” rating and set a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. JPMorgan Chase & Co. lowered their target price on Clorox from $173.00 to $151.00 and set a “neutral” rating for the company in a report on Friday, April 11th. Citigroup cut their price target on Clorox from $165.00 to $150.00 and set a “neutral” rating on the stock in a report on Monday, April 14th. Finally, Barclays decreased their price objective on Clorox from $139.00 to $134.00 and set an “underweight” rating for the company in a research note on Friday, April 11th. Three analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $153.83.

Clorox Trading Up 2.0 %

CLX stock opened at $139.60 on Thursday. The company has a market capitalization of $17.20 billion, a PE ratio of 38.14, a P/E/G ratio of 2.62 and a beta of 0.61. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. Clorox has a 12 month low of $127.60 and a 12 month high of $171.37. The firm’s 50-day moving average is $146.57 and its 200 day moving average is $156.45.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period last year, the business earned $2.16 earnings per share. On average, research analysts anticipate that Clorox will post 7.15 EPS for the current year.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the stock. Norges Bank purchased a new position in shares of Clorox during the 4th quarter valued at approximately $259,041,000. FMR LLC increased its holdings in Clorox by 75.4% in the fourth quarter. FMR LLC now owns 1,361,758 shares of the company’s stock valued at $221,163,000 after buying an additional 585,526 shares in the last quarter. Marshall Wace LLP raised its position in shares of Clorox by 549.8% in the fourth quarter. Marshall Wace LLP now owns 542,726 shares of the company’s stock worth $88,144,000 after acquiring an additional 459,203 shares during the period. ExodusPoint Capital Management LP boosted its stake in shares of Clorox by 187.9% during the 4th quarter. ExodusPoint Capital Management LP now owns 698,900 shares of the company’s stock worth $113,508,000 after acquiring an additional 456,114 shares in the last quarter. Finally, Man Group plc grew its position in shares of Clorox by 154.6% during the 4th quarter. Man Group plc now owns 570,503 shares of the company’s stock valued at $92,655,000 after acquiring an additional 346,449 shares during the period. 78.53% of the stock is owned by institutional investors and hedge funds.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.